Statement Of Cash Flows

Daito Pharmaceutical Co., Ltd. - Filing #7730500

Concept	As at 2017-11-30	2017-06-01 to 2017-11-30	As at 2017-05-31	2016-06-01 to 2016-11-30	As at 2016-11-30	As at 2016-05-31
Statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal	—	2,511,413,000 JPY	—	2,391,674,000 JPY	—	—
Interest and dividends received	—	40,716,000 JPY	—	41,135,000 JPY	—	—
Interest paid	—	-13,972,000 JPY	—	-14,796,000 JPY	—	—
Income taxes paid	—	-963,606,000 JPY	—	-304,375,000 JPY	—	—
Net cash provided by (used in) operating activities	—	1,613,239,000 JPY	—	2,143,030,000 JPY	—	—
Cash flows from operating activities
Cash flows from operating activities
Cash flows from investing activities
Purchase of property, plant and equipment	—	-1,984,829,000 JPY	—	-1,340,611,000 JPY	—	—
Net cash provided by (used in) investing activities	—	-2,004,371,000 JPY	—	-1,330,043,000 JPY	—	—
Other, net	—	-15,552,000 JPY	—	12,649,000 JPY	—	—
Cash flows from facilities maintenance and investing activities
Cash flows from financing activities
Purchase of treasury shares	—	-493,000 JPY	—	-139,000 JPY	—	—
Proceeds from long-term borrowings	—	1,100,000,000 JPY	—	1,000,000,000 JPY	—	—
Dividends paid	—	-223,327,000 JPY	—	-187,751,000 JPY	—	—
Net cash provided by (used in) financing activities	—	472,198,000 JPY	—	-519,957,000 JPY	—	—
Repayments of long-term borrowings	—	-1,134,797,000 JPY	—	-1,168,169,000 JPY	—	—
Effect of exchange rate change on cash and cash equivalents	—	12,917,000 JPY	—	-21,627,000 JPY	—	—
Net increase (decrease) in cash and cash equivalents	—	93,983,000 JPY	—	271,401,000 JPY	—	—
Cash and cash equivalents	1,711,320,000 JPY	—	1,617,337,000 JPY	—	1,622,536,000 JPY	1,351,135,000 JPY